Creavo Medical Technologies, a UK-based, privately held medical devices company, has announced the appointment of John von Benecke as Chief Financial Officer (CFO) to help the company with its next phase of growth as it nears the commercialisation of its first device.

Mr von Benecke previous experience spans CFO roles at medical technology start-ups, including Veryan Medical, Cellnovo and ApaTech, and senior finance roles at blue chip healthcare companies like Abbott Laboratories.

He has more than 15 years’ experience in the healthcare industry and a decade of experience working for start-ups and venture capital and private equity-backed businesses, during which time he has raised a total of more than $100 million of equity and debt and taken companies through to successful exits.

In his role at Creavo, he will be responsible for the overall financial function at the company, as well as working closely with the CEO on fundraising, commercial strategy and financial planning.

Steve Parker, Chief Executive Officer at Creavo Medical Technologies, said: “John brings with him a wealth of experience in both the medical industry and private equity backed businesses which makes him the perfect fit for us. His expertise will be invaluable as we take VitalScan through clinical trials and move ever closer to commercialisation.

“VitalScan could change the cardiac triage process across the world quite dramatically and John has the right experience to support us in the months and years ahead where we will potentially experience rapid growth. We are very pleased to have him as part of the team.”

Commenting on his appointment, Mr von Benecke said: “Creavo is a forward-looking, innovative company with a product that could drive real change in healthcare markets globally. Having worked with many organisations that are at a similar stage of maturity to Creavo, I fully understand the challenges and opportunities that lie ahead. I look forward to working closely with Steve and the team to support Creavo’s next phase of growth.”

Creavo Medical Technologies is a UK-based, privately held medical device company that was formed in 2014 to bring to market innovative technology developed by Professor Ben Varcoe at the University of Leeds. The first application of this technology is VitalScan, a device that meets an urgent clinical need in global cardiology to rule out heart-related problems at point of admission to emergency departments, ensuring patients with chest pain access the right treatment faster.